Phillip Gambel

Array ( [id] => 8707531 [patent_doc_number] => 20130064820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING DEGOS\' DISEASE' [patent_app_type] => utility [patent_app_number] => 13/582018 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25006 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950014 [patent_doc_number] => 20130195794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'CANCER VACCINE' [patent_app_type] => utility [patent_app_number] => 13/581113 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 5259 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6183785 [patent_doc_number] => 20110123531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 13/019183 [patent_app_country] => US [patent_app_date] => 2011-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15219 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123531.pdf [firstpage_image] =>[orig_patent_app_number] => 13019183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8720191 [patent_doc_number] => 20130071408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'Methods for Diagnosis and Treatment of Non-Insulin Dependent Diabetes Mellitus' [patent_app_type] => utility [patent_app_number] => 13/575904 [patent_app_country] => US [patent_app_date] => 2011-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 26859 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8648838 [patent_doc_number] => 20130034568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'METHODS OF TREATING OR PREVENTING PERIODONTITIS AND DISEASES ASSOCIATED WITH PERIODONTITIS' [patent_app_type] => utility [patent_app_number] => 13/574542 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 15937 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6110112 [patent_doc_number] => 20110189139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Hematopoietic Cell E-Selectin/L-Selectin Ligand Glycosylated CD44 Polypeptide' [patent_app_type] => utility [patent_app_number] => 13/012367 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 26728 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20110189139.pdf [firstpage_image] =>[orig_patent_app_number] => 13012367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102130 [patent_doc_number] => 20110165622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/007061 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17536 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165622.pdf [firstpage_image] =>[orig_patent_app_number] => 13007061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6183759 [patent_doc_number] => 20110123528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/007142 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17532 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123528.pdf [firstpage_image] =>[orig_patent_app_number] => 13007142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038423 [patent_doc_number] => 20110091472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'COMPOSITIONS FOR TREATING PSORIASIS' [patent_app_type] => utility [patent_app_number] => 12/979081 [patent_app_country] => US [patent_app_date] => 2010-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8698 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091472.pdf [firstpage_image] =>[orig_patent_app_number] => 12979081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943562 [patent_doc_number] => 20110104182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'CD40 ANTIBODY FORMULATION AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/978272 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7771 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104182.pdf [firstpage_image] =>[orig_patent_app_number] => 12978272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9843655 [patent_doc_number] => 08945565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies' [patent_app_type] => utility [patent_app_number] => 12/974739 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 28477 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 260 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12974739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8683947 [patent_doc_number] => 20130052231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'TREATMENT METHODS UTILIZING STEM CELL MOBILIZERS AND IMMUNOSUPPRESSIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 13/515143 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12760 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8683947 [patent_doc_number] => 20130052231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'TREATMENT METHODS UTILIZING STEM CELL MOBILIZERS AND IMMUNOSUPPRESSIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 13/515143 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12760 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8393169 [patent_doc_number] => 20120231008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'Anti-C5A Binding Moieties with High Blocking Activity' [patent_app_type] => utility [patent_app_number] => 13/512334 [patent_app_country] => US [patent_app_date] => 2010-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23799 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6031974 [patent_doc_number] => 20110081666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'ANTI-PSGL-1 INHIBITORS AND SCREENING METHODS' [patent_app_type] => utility [patent_app_number] => 12/946372 [patent_app_country] => US [patent_app_date] => 2010-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22883 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20110081666.pdf [firstpage_image] =>[orig_patent_app_number] => 12946372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6190116 [patent_doc_number] => 20110172400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'COMPOSITIONS MONOVALENT FOR CD40L BINDING AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/941870 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 51338 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20110172400.pdf [firstpage_image] =>[orig_patent_app_number] => 12941870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000542 [patent_doc_number] => 20110117021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'FULLY HUMAN ANTI-VAP-1 MONOCLONAL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/940476 [patent_app_country] => US [patent_app_date] => 2010-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15147 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117021.pdf [firstpage_image] =>[orig_patent_app_number] => 12940476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453265 [patent_doc_number] => 20120264212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'COMPOUNDS AND METHODS FOR INHIBITING THE METASTASIS OF CANCER CELLS' [patent_app_type] => utility [patent_app_number] => 13/508255 [patent_app_country] => US [patent_app_date] => 2010-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 15823 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8370603 [patent_doc_number] => 20120219991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'CLONAL EXPANSION OF B CELLS' [patent_app_type] => utility [patent_app_number] => 13/504638 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19360 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676633 [patent_doc_number] => 08815543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Methods of producing antigen-specific B cell populations in the presence of CD40:CD40L, BAFF:BAFF receptor and Fas:FasL stimulation' [patent_app_type] => utility [patent_app_number] => 13/504111 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 10814 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504111 [rel_patent_id] =>[rel_patent_doc_number] =>)